Natixis Advisors
SEM

Natixis Advisors’s Select Medical SEM Stock Holding History

Natixis Advisors’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
21,917
-2,466
-10% -$40.6K ﹤0.01% 1760
2026
Q1 		$397K Buy
24,383
+1,553
+7% +$24.3K ﹤0.01% 1597
2025
Q4 		$339K Buy
+22,830
New +$323K ﹤0.01% 1532
2025
Q3 		– Sell
-13,840
Closed -$210K – 1686
2025
Q2 		$210K Sell
13,840
-10,103
-42% -$158K ﹤0.01% 1588
2025
Q1 		$400K Sell
23,943
-4,260
-15% -$78.4K ﹤0.01% 1503
2024
Q4 		$532K Sell
28,203
-18,752
-40% -$362K ﹤0.01% 1457
2024
Q3 		$882K Sell
46,955
-2,155
-4% -$41.3K ﹤0.01% 1330
2024
Q2 		$928K Buy
49,110
+5,156
+12% +$87.9K ﹤0.01% 1278
2024
Q1 		$714K Buy
43,954
+9,765
+29% +$143K ﹤0.01% 1303
2023
Q4 		$432K Sell
34,189
-11,257
-25% -$142K ﹤0.01% 1415
2023
Q3 		$619K Sell
45,446
-3,827
-8% -$59.1K ﹤0.01% 1312
2023
Q2 		$846K Buy
49,273
+6,104
+14% +$94.6K ﹤0.01% 1207
2023
Q1 		$601K Buy
43,169
+6,799
+19% +$100K ﹤0.01% 1266
2022
Q4 		$487K Sell
36,370
-1,095
-3% -$14.2K ﹤0.01% 1301
2022
Q3 		$446K Sell
37,465
-13,445
-26% -$191K ﹤0.01% 1307
2022
Q2 		$648K Buy
50,910
+32,151
+171% +$413K ﹤0.01% 1216
2022
Q1 		$242K Sell
18,759
-697
-4% -$9.2K ﹤0.01% 1404
2021
Q4 		$308K Sell
19,456
-17,573
-47% -$300K ﹤0.01% 1316
2021
Q3 		$722K Buy
37,029
+5,716
+18% +$113K ﹤0.01% 1145
2021
Q2 		$713K Buy
31,313
+6,246
+25% +$130K ﹤0.01% 1158
2021
Q1 		$460K Buy
+25,067
New +$411K ﹤0.01% 1178
2020
Q2 		– Sell
-76,532
Closed -$619K – 1193
2020
Q1 		$619K Buy
+76,532
New +$909K 0.01% 1010

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Natixis Advisors's SEM Position: Q2 2026 in Review

Natixis Advisors reduced its Select Medical (SEM) stake by 10% in Q2 2026, selling an estimated $40.6K and leaving 21,917 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

Natixis Advisors first reported a position in SEM in Q1 2020 and has held it in 22 quarters since. The position peaked at $928K in Q2 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Natixis Advisors held 21,917 shares of Select Medical worth $361K as of Q2 2026.
  • Natixis Advisors sold 2,466 Select Medical shares in Q2 2026, an estimated $40.6K.
  • Select Medical made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1760 holding.
  • Natixis Advisors first reported a position in Select Medical in Q1 2020 and has held it in 22 quarters since.
  • Natixis Advisors's Select Medical position peaked at $928K in Q2 2024.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.